VGR Australia VGR Australia

Tibofem
Tibofem

3.12
This therapeutic option mimics endogenous hormones to balance regulatory processes.
Ingredient
Estradiol
Category
Menopause & HRT
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Estradiol
Reference Brand
Estradiol
Product Origin
Generic Brand
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Women's Health
Product Category
Estrogen
Pharmacological Class
Natural Hormone
Manufacturer Description
Formulated for menopausal symptoms to manage hormonal balance and support bone health.
Mechanism of Action
This medication replaces the naturally occurring hormone estradiol. It regulates gene transcription in target tissues to alleviate hot flashes and vaginal dryness while maintaining bone density in postmenopausal women.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
History of thromboembolic disorders, Breast cancer, Undiagnosed uterine bleeding, Pregnancy
Severe Adverse Events
Deep vein thrombosis, Stroke, Endometrial cancer — requires immediate medical attention
Common Side Effects
Nausea, Breast tenderness, Headache
Uncommon Side Effects
Weight changes, Mood fluctuations, Edema
Drug Interactions
Alcohol, Tobacco, Rifampin, Warfarin
Pregnancy Safety Warnings
FDA Category X: Strictly contraindicated in pregnancy. Breastfeeding: Not recommended.
Age Restrictions
Indicated for postmenopausal women only.
Storage Guidelines
Store below 25°C away from moisture.
Related Products
Progynova, Estradot, Zumenon
Information related to Tibofem is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
How to buy Pain Management Drugs - Naproxen Price Ireland